Zobrazeno 1 - 10
of 776
pro vyhledávání: '"Volker, Diehl"'
Autor:
Peter Borchmann, Alden Moccia, Richard Greil, Mark Herzberg, Alexander Fosså, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Valdete Schaub, Mathias Hänel, Urban Novak, Julia Meissner, Johannes Hellmuth, Stephan Mathas, Josée. M. Zijlstra, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratush Giri, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Andreas Rosenwald, Wolfram Klapper, Hans Theodor Eich, Christian Baues, Michael Hallek, Carsten Kobe, Volker Diehl, Andreas Engert
Publikováno v:
HemaSphere, Vol 6, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/fae1700f06054ad8892e302518d602fa
Autor:
Conrad-Amadeus Voltin, Stefanie Kreissl, Helen Kaul, Ina Bühnen, Jasmin Mettler, Thomas Pabst, Dennis A. Eichenauer, Michael Fuchs, Volker Diehl, Markus Dietlein, Andreas Engert, Peter Borchmann, Carsten Kobe
Publikováno v:
HemaSphere, Vol 6, Pp 4-4 (2022)
Externí odkaz:
https://doaj.org/article/9d738ed021664e5d83f3f389ac4c95a9
Autor:
Peter Borchmann, Alden Moccia, Richard Greil, Mark Hertzberg, Valdete Schaub, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Mathias Haenel, Urban Novak, Julia Meissner, Andreas Zimmermann, Stephan Mathas, Josée M. Zijlstra, Alexander Fosså, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratyush Giri, Peter Kamper, Daniel Molin, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Andreas Rosenwald, Wolfram Klapper, Hans Eich, Christian Baues, Michael Hallek, Markus Dietlein, Carsten Kobe, Volker Diehl, Andreas Engert
Publikováno v:
Blood. 140:771-773
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d468000e8dad7bd0b927c73580f864ee
https://doi.org/10.1182/blood-2022-165917
https://doi.org/10.1182/blood-2022-165917
Autor:
Andreas Engert, Helen Goergen, Jana Markova, Thomas Pabst, Julia Meissner, Josée M. Zijlstra, Zdenek Král, Dennis A. Eichenauer, Martin Soekler, Richard Greil, Stefanie Kreissl, Ruth Scheuvens, Hans Eich, Carsten Kobe, Markus Dietlein, Harald Stein, Michael Fuchs, Volker Diehl, Peter Borchmann
Publikováno v:
HemaSphere, Vol 1, Iss 1 (2017)
Abstract. The international, randomized phase 3 HD15 trial established 6xeBEACOPP as standard therapy for patients with newly diagnosed advanced-stage Hodgkin lymphoma (HL) within the German Hodgkin Study Group (GHSG). We performed a follow-up analys
Externí odkaz:
https://doaj.org/article/5bbc60c61afa496f9b084c2273b060f5
Autor:
Josée M. Zijlstra, Stefan Balabanov, Carsten Kobe, Hans Theodor Eich, Richard Greil, Julia Meissner, Alden A. Moccia, Teresa V Halbsguth, Volker Diehl, Paul J Bröckelmann, Judith Dierlamm, Ulrich Keller, Bastian von Tresckow, Christian Baues, Michael Fuchs, Annette Plütschow, Helmut Ostermann, Simone Marnitz, Martin Wilhelm, Sonja Martin, Beate Klimm, Julia Thiemer, Peter Borchmann, Thomas Pabst, Johannes Mohm, Michael Hallek, Andreas Rosenwald, Markus Dietlein, Andreas Hüttmann, Martin Vogelhuber, Max S. Topp, Martin Sökler, Andreas Engert, Andrea Kerkhoff, Miriam Ahlborn, Georg Kuhnert
Publikováno v:
The Lancet Oncology, 22(2), 223-234. Lancet Publishing Group
Borchmann, P, Plütschow, A, Kobe, C, Greil, R, Meissner, J, Topp, M S, Ostermann, H, Dierlamm, J, Mohm, J, Thiemer, J, Sökler, M, Kerkhoff, A, Ahlborn, M, Halbsguth, T V, Martin, S, Keller, U, Balabanov, S, Pabst, T, Vogelhuber, M, Hüttmann, A, Wilhelm, M, Zijlstra, J M, Moccia, A, Kuhnert, G, Bröckelmann, P J, von Tresckow, B, Fuchs, M, Klimm, B, Rosenwald, A, Eich, H, Baues, C, Marnitz, S, Hallek, M, Diehl, V, Dietlein, M & Engert, A 2021, ' PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial ', The Lancet Oncology, vol. 22, no. 2, pp. 223-234 . https://doi.org/10.1016/S1470-2045(20)30601-X
Strahlentherapie Und Onkologie
Borchmann, P, Plütschow, A, Kobe, C, Greil, R, Meissner, J, Topp, M S, Ostermann, H, Dierlamm, J, Mohm, J, Thiemer, J, Sökler, M, Kerkhoff, A, Ahlborn, M, Halbsguth, T V, Martin, S, Keller, U, Balabanov, S, Pabst, T, Vogelhuber, M, Hüttmann, A, Wilhelm, M, Zijlstra, J M, Moccia, A, Kuhnert, G, Bröckelmann, P J, von Tresckow, B, Fuchs, M, Klimm, B, Rosenwald, A, Eich, H, Baues, C, Marnitz, S, Hallek, M, Diehl, V, Dietlein, M & Engert, A 2021, ' PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial ', The Lancet Oncology, vol. 22, no. 2, pp. 223-234 . https://doi.org/10.1016/S1470-2045(20)30601-X
Strahlentherapie Und Onkologie
Background: Combined-modality treatment consisting of chemotherapy and consolidation radiotherapy is standard of care for patients with early-stage unfavourable Hodgkin lymphoma. However, the use of radiotherapy can have long-term sequelae, which is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f13d466acfe65ac8d5c77ff231c4382
https://doi.org/10.1016/s1470-2045(20)30601-x
https://doi.org/10.1016/s1470-2045(20)30601-x
Autor:
Oliver A. Cornely, Jens Chemnitz, Hans-Georg Brochhagen, Karin Lemmer, Heidi Schütt, Dietmar Söhngen, Peter Staib, Claudia Wickenhauser, Volker Diehl, Kathrin Tintelnot
Publikováno v:
Emerging Infectious Diseases, Vol 7, Iss 1, Pp 149-152 (2001)
We report Neocosmospora vasinfecta infection following chemotherapy for acute nonlymphocytic leukemia. N. vasinfecta, a plant pathogen, was identified by culture and genetic sequencing. Susceptibility testing revealed in vitro resistance for common a
Externí odkaz:
https://doaj.org/article/8bc2ddee85174b77a233c688cf208fd3
Autor:
Peter Borchmann, Richard Greil, Volker Diehl, Josée M. Zijlstra, Jana Markova, Julia Meissner, Sarah Gillessen, Andreas Engert, Max S. Topp, Annette Plütschow, Dennis A. Eichenauer, Bastian von Tresckow, Michael Fuchs, Paul J Bröckelmann
Publikováno v:
Gillessen, S, Plütschow, A, Fuchs, M, Markova, J, Greil, R, Topp, M S, Meissner, J, Zijlstra, J M, Eichenauer, D A, Bröckelmann, P J, Diehl, V, Borchmann, P, Engert, A & von Tresckow, B 2021, ' Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14) ', The Lancet Haematology, vol. 8, no. 4, pp. e278-e288 . https://doi.org/10.1016/S2352-3026(21)00029-6
The Lancet Haematology, 8(4), e278-e288. Lancet Publishing Group
The Lancet Haematology, 8(4), e278-e288. Lancet Publishing Group
Summary Background To improve the long-term tumour control in early, unfavourable Hodgkin Lymphoma, the German Hodgkin Study Group (GHSG) HD14 trial compared four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) with an intensifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57cfeea8e46362c19db45e3507629e0b
https://research.vumc.nl/en/publications/c1e461ac-5125-4d24-8c7e-10b59a9ac174
https://research.vumc.nl/en/publications/c1e461ac-5125-4d24-8c7e-10b59a9ac174
Autor:
Stefanie Kreissl, Conrad‐Amadeus Voltin, Helen Kaul, Ina Bühnen, Jasmin Mettler, Thomas Pabst, Dennis A. Eichenauer, Michael Fuchs, Volker Diehl, Markus Dietlein, Andreas Engert, Peter Borchmann, Carsten Kobe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18d3589cc260b620f12fc87dd8b611bc
Autor:
Hans Theodor Eich, Andreas Engert, Bernd Hertenstein, Felicitas Hitz, Walter E. Aulitzky, Peter Borchmann, Harald Stein, Michael Fuchs, Hans-Joachim Beck, Martin Bentz, Markus Dietlein, Julia Meissner, Max S. Topp, Helen Goergen, Ina Buehnen, Dennis A. Eichenauer, Carsten Kobe, Richard Greil, Jana Markova, Thomas Pabst, Wolfgang Willenbacher, Alden A. Moccia, Christian Baues, Martin Soekler, Helmut Ostermann, Volker Diehl, Georg Maschmeyer, Wolf-Dieter Ludwig, Dagmar Kühnhardt, Ulrich Keller, Tom Vieler, Stefanie Kreissl, Michaela Feuring-Buske, Josée M. Zijlstra
Publikováno v:
German Hodgkin Study Group 2021, ' PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial ', Lancet haematology, vol. 8, no. 6, pp. e398-e409 . https://doi.org/10.1016/S2352-3026(21)00101-0
Lancet haematology, 8(6), e398-e409. Lancet Publishing Group
Lancet haematology, 8(6), e398-e409. Lancet Publishing Group
Summary Background The German Hodgkin Study Group's HD18 trial established the safety and efficacy of PET-guided eBEACOPP (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone in escalated doses) for the trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b22896e8e075319dccb339ecf7a6c4c9
https://pubmed.ncbi.nlm.nih.gov/34048679
https://pubmed.ncbi.nlm.nih.gov/34048679
Autor:
Helen Goergen, Bastian von Tresckow, Michael Fuchs, Peter Borchmann, Andreas Engert, Volker Diehl, Boris Böll, Dennis A. Eichenauer, Leonard Elger, Stefanie Kreissl, Horst Müller
Publikováno v:
British journal of haematologyReferences. 193(3)
Data on non-Hodgkin lymphoma (NHL) after classical Hodgkin lymphoma (cHL) are scarce. We therefore performed a retrospective analysis comprising 11·841 cHL patients who had first-line treatment within the randomized German Hodgkin Study Group (GHSG)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3a17af8d38d1c6ed2d8e491e1365e20
https://pubmed.ncbi.nlm.nih.gov/33486762
https://pubmed.ncbi.nlm.nih.gov/33486762